On 12 February 2015
Glenmark Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 February 2015, to consider and approve the Company's Unaudited Financial Statements for the Third Quarter ended 31 December 2014 (Q3).Powered by Capital Market - Live News